{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The identification of PINK1 mutations associated with recessive parkinsonism suggests... the recessive nature of the PINK1 mutations suggests that loss of function is associated with disease, further implying that the PINK1 kinase activity is important in protecting nigral neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as loss of function of PINK1 kinase activity leading to recessive parkinsonism, with implications for nigral neuron protection."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In this study, we examined whether mutations in PINK1 affect kinase activity by using the autophosphorylation assay previously shown to be useful for this protein in vitro.",
          "judgment": "Yes",
          "reasoning": "The autophosphorylation assay is a general class of assay used to assess kinase activity, which directly relates to the disease mechanism of loss of function in PINK1 associated with parkinsonism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We next measured autophosphorylation of PINK1 variants... Wild-type PINK1 (lane 1) is shown for comparison with artificial kinase mutants (K219A, lane 2; D362A, lane 3; D384A, lane 4; triple kinase-dead mutant, lane 5)... Differences in autophosphorylation activity between different recombinant proteins (n = 3) were analyzed by using ANOVA with Fisher's PLSD post hoc test.",
          "judgment": "Yes",
          "reasoning": "The paper includes both normal (wild-type PINK1) and abnormal (artificial kinase-dead mutants) controls in the autophosphorylation assay. It also explicitly states that experiments were performed with replicates (n=3), meeting the criteria for basic controls and replicates.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "We tested two recessive mutations and found that although G309D had somewhat decreased activity (60.5% of wild type; P = 0.01)...",
          "judgment": "No",
          "reasoning": "While the paper tests the G309D mutation, it does not explicitly use known pathogenic or benign variant controls beyond the artificial kinase-dead mutants and the wild-type. There is no mention of variants reaching P/LP or B/LB criteria without relying on PS3/BS3 evidence.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for PINK1 G309D is rated as PS3_supporting due to the demonstrated decrease in kinase activity (60.5% of wild-type) in a relevant autophosphorylation assay with basic controls and replicates. However, the lack of specific variant controls limits the strength to supporting."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The identification of PINK1 mutations associated with recessive parkinsonism suggests... the recessive nature of the PINK1 mutations suggests that loss of function is associated with disease, further implying that the PINK1 kinase activity is important in protecting nigral neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as loss of function of PINK1 kinase activity leading to recessive parkinsonism, with implications for nigral neuron protection."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In this study, we examined whether mutations in PINK1 affect kinase activity by using the autophosphorylation assay previously shown to be useful for this protein in vitro.",
          "judgment": "Yes",
          "reasoning": "The autophosphorylation assay is a general class of assay used to assess kinase activity, which directly relates to the disease mechanism of loss of function in PINK1 associated with parkinsonism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We next measured autophosphorylation of PINK1 variants... Wild-type PINK1 (lane 1) is shown for comparison with artificial kinase mutants (K219A, lane 2; D362A, lane 3; D384A, lane 4; triple kinase-dead mutant, lane 5)... Differences in autophosphorylation activity between different recombinant proteins (n = 3) were analyzed by using ANOVA with Fisher's PLSD post hoc test.",
          "judgment": "Yes",
          "reasoning": "The paper includes both normal (wild-type PINK1) and abnormal (artificial kinase-dead mutants) controls in the autophosphorylation assay. It also explicitly states that experiments were performed with replicates (n=3), meeting the criteria for basic controls and replicates.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "We tested two recessive mutations and found that... L347P had drastically decreased activity (<10% of wild type).",
          "judgment": "No",
          "reasoning": "While the paper tests the L347P mutation, it does not explicitly use known pathogenic or benign variant controls beyond the artificial kinase-dead mutants and the wild-type. There is no mention of variants reaching P/LP or B/LB criteria without relying on PS3/BS3 evidence.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for PINK1 L347P is rated as PS3_supporting due to the drastic decrease in kinase activity (<10% of wild-type) and protein instability in a relevant autophosphorylation assay with basic controls and replicates. However, the lack of specific variant controls limits the strength to supporting."
    }
  ]
}